Patenting strategies, the authentication US fiscal methodology, discovery and development of imidazole-containing peptide compounds with free-radical scavenging and transglycating properties acting as targeted drug regulators and homeostatic agents with diverse therapeutic activities for pharmacy of diabetes and metabolic diseases

Mark A Babizhayev

Open source

DOI
10.1517/13543776.2015.1064899
Published
2015-09-15
Container
Expert Opinion on Therapeutic Patents
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1517/13543776.2015.1064899,
  title = {Patenting strategies, the authentication US fiscal methodology, discovery and development of imidazole-containing peptide compounds with free-radical scavenging and transglycating properties acting as targeted drug regulators and homeostatic agents with diverse therapeutic activities for pharmacy of diabetes and metabolic diseases},
  author = {Mark A Babizhayev},
  year = {2015},
  journal = {Expert Opinion on Therapeutic Patents},
  doi = {10.1517/13543776.2015.1064899},
  url = {https://doi.org/10.1517/13543776.2015.1064899}
}

RIS

TY  - JOUR
TI  - Patenting strategies, the authentication US fiscal methodology, discovery and development of imidazole-containing peptide compounds with free-radical scavenging and transglycating properties acting as targeted drug regulators and homeostatic agents with diverse therapeutic activities for pharmacy of diabetes and metabolic diseases
AU  - Mark A Babizhayev
PY  - 2015
JO  - Expert Opinion on Therapeutic Patents
DO  - 10.1517/13543776.2015.1064899
UR  - https://doi.org/10.1517/13543776.2015.1064899
ER  - 

APA

Babizhayev, M. A. (2015). Patenting strategies, the authentication US fiscal methodology, discovery and development of imidazole-containing peptide compounds with free-radical scavenging and transglycating properties acting as targeted drug regulators and homeostatic agents with diverse therapeutic activities for pharmacy of diabetes and metabolic diseases. Expert Opinion on Therapeutic Patents. https://doi.org/10.1517/13543776.2015.1064899

Source records